Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Gastroenterology|April 1, 1988
5-Aminosalicylic acid enemas: effective agent in maintaining remission in left-sided ulcerative colitisW L Biddle, N J Greenberger, J T Swan, et al.The American Journal of the Medical Sciences|September 1, 1989
Oral calcium chloride in hypoparathyroidism refractory to massive doses of calcium carbonate and vitamin DS Komindr, L W Schmidt, G M PalmieriAlimentary Pharmacology & Therapeutics|March 6, 2002
Effects of antacid formulation on postprandial oesophageal acidity in patients with a history of episodic heartburnM Robinson, S Rodriguez-Stanley, P B Miner, et al.Gastroenterology|December 1, 1986
Superficially invasive squamous cell carcinoma of the esophagus. A study of seven cases in Memphis, TennesseeL W Schmidt, P J Dean, R T WilsonAlimentary Pharmacology & Therapeutics|July 15, 1998
Psyllium is superior to docusate sodium for treatment of chronic constipationJ W McRorie, B P Daggy, J G Morel, et al.Alimentary Pharmacology & Therapeutics|September 13, 2001
Synergy between low-dose ranitidine and antacid in decreasing gastric and oesophageal acidity and relieving meal-induced heartburnM Robinson, S Rodriguez-Stanley, A A Ciociola, et al.Alimentary Pharmacology & Therapeutics|May 4, 2006
A phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitisS J H van Deventer, M K Wedel, B F Baker, et al.Alimentary Pharmacology & Therapeutics|May 4, 2006
Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitisP B Miner, R S Geary, J Matson, et al.Alimentary Pharmacology & Therapeutics|February 12, 2010
Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitorsP B Miner, L A McKean, R D Gibb, et al.Alimentary Pharmacology & Therapeutics|December 21, 2000
Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trialN J Talley, M Verlinden, W Snape, et al.Pageof 7